What Is an RL in Healthcare and How Does It Work?

Reinforcement learning, or RL, is a branch of artificial intelligence in which a software agent learns to make decisions by trial and error, receiving rewards for good outcomes and penalties for bad ones. In healthcare, RL is being developed to tackle problems where treatment decisions unfold over time and must be adjusted as a patient’s condition changes. Rather than following a single static guideline, an RL system learns a strategy (called a “policy”) for choosing actions at each step, whether that means adjusting an insulin dose, selecting a drug combination, or scheduling operating rooms. The technology is still largely in the research and simulation stage, but its range of applications is surprisingly broad.

The Core Idea Behind RL in Medicine

Most people are familiar with AI that classifies things: look at a scan, label it cancerous or benign. RL works differently. Instead of making a single prediction, an RL agent makes a sequence of decisions, observes what happens after each one, and gradually learns which sequences tend to produce the best long-term results. Think of it like a chess player who doesn’t just evaluate the board right now but plans several moves ahead, trying to maximize their chances of winning the game.

In a clinical setting, the “game” might be managing a critically ill patient’s blood pressure over the next 48 hours. The agent observes the patient’s current vital signs and lab results (the “state”), chooses an action like increasing a medication dose, and then sees how the patient responds. A positive response earns a reward; deterioration earns a penalty. Over many training episodes drawn from historical patient records, the agent discovers patterns linking states, actions, and outcomes that even experienced clinicians might not spot consistently.

Researchers typically frame these problems as Markov Decision Processes, which assume that the current state contains enough information to decide what to do next. In practice, healthcare decisions don’t always fit that assumption neatly. Visits and measurements happen at irregular intervals, and the “true” state of a patient’s disease may be partially hidden behind imperfect test results.¹ Researchers have developed extensions, including semi-Markov models and hidden-state models, to deal with these real-world messiness factors.²

Why Clinicians Can’t Just Trial-and-Error on Real Patients

A chess-playing AI can play millions of games against itself. A healthcare RL agent obviously can’t experiment on real patients. So the vast majority of healthcare RL systems learn “offline,” meaning they train on historical records from electronic health records or clinical databases. The agent never takes an action in the real world during training. Instead, it studies what clinicians actually did, what happened next, and tries to figure out whether a different decision would have led to a better outcome.

This offline approach introduces its own difficulties. The agent might propose a treatment combination that was rarely or never tried in the historical data, leaving it with little evidence about what would happen. One popular technique called Conservative Q-Learning deliberately underestimates the expected benefit of treatments that appear infrequently in the data, keeping the agent from recommending actions it can’t support with evidence.³ The philosophy is cautious: if you haven’t seen enough examples of a treatment working, don’t recommend it.

Sepsis and ICU Care

Sepsis management in intensive care units has become the most studied use case for healthcare RL. Sepsis kills hundreds of thousands of people annually in the United States alone, and treatment decisions about intravenous fluids and blood-pressure-raising drugs (vasopressors) are both urgent and highly variable. A study of emergency department patients found that nearly half of those meeting sepsis criteria received no IV fluids or vasopressors in the first six hours, and among those who were treated, the timing and amounts varied widely.⁴ That variability is both a clinical concern and a data opportunity: it means the historical record contains many different treatment strategies whose outcomes can be compared.

RL models trained on the large MIMIC-III critical care database have shown promising results in retrospective analyses. One deep RL system estimated that patients whose actual treatments matched the AI’s recommended dosing survived at rates up to about ten percentage points higher than the dataset average.⁵ Other models have been specifically developed to suggest optimal fluid and vasopressor dosing aimed at improving 90-day survival.⁶

A critical caveat: these are retrospective estimates, not prospective trials. The models look backward at what happened and calculate what might have been. No RL system has yet been tested in a randomized trial for sepsis management, and the same study that documented treatment variability also raised serious concerns about model transportability, meaning an RL policy trained on one hospital’s data may not work well at another.⁴

Automated Insulin Delivery

Managing Type 1 diabetes requires constant insulin adjustments in response to meals, exercise, stress, and dozens of other factors. RL is being explored as the brain of “artificial pancreas” systems that read continuous glucose monitor data and decide how much insulin to deliver, minute by minute, without the person needing to count carbohydrates or manually bolus.

In simulation studies, RL-based controllers have achieved encouraging performance. One system using a safety-enhanced version of the Proximal Policy Optimization algorithm reached a median time-in-range of about 87%, meaning glucose stayed in the safe zone for the large majority of a simulated day, while eliminating severe low-blood-sugar events entirely.⁷ A “dual controller” approach that personalized insulin bounds for each patient improved time-in-range to about 69% compared with roughly 62% for a single-model approach, while reducing dangerous glucose spikes.⁸ Another model maintained glucose in the target range about 64% of the time while keeping predictions stable and close to actual values.⁹

These numbers come from software simulators, not real human bodies. The gap between a mathematical model of glucose metabolism and an actual person eating pizza at midnight is substantial. Still, the direction is clear: RL could eventually let people with diabetes offload much of the cognitive burden of self-management to an automated system. Unlike conventional pump algorithms that rely on fixed rules, an RL controller adapts its strategy over time as it learns a person’s individual patterns.

Ventilator Management and Sedation

Deciding when to take a patient off a ventilator and how much sedation to give are judgment calls that carry real risk in both directions. Extubate too early and the patient may crash; keep someone sedated too long and recovery slows. RL has been applied to learn the implicit priorities clinicians use when making these decisions. One study using inverse reinforcement learning, a technique that works backward from expert behavior to infer what goals the expert was pursuing, found that clinicians weigh physiological stability indicators like heart rate and breathing rate more heavily than oxygenation metrics when deciding on extubation readiness and sedative doses.¹⁰ By making these implicit priorities explicit, RL could help standardize ventilator weaning protocols and suggest new treatment approaches.

Radiation Therapy Planning

Creating a radiation treatment plan for cancer is a painstaking process. A human planner must balance delivering enough radiation to the tumor while sparing surrounding healthy tissues, adjusting dozens of parameters through a back-and-forth process that can take hours. RL agents are being trained to automate this iterative tuning.

For head-and-neck cancer, an RL agent generated clinically acceptable intensity-modulated plans in roughly 12 minutes without human intervention. The plans delivered a lower maximum dose to the tumor target area (about 109% versus 112% for human-made plans) while keeping doses to nearby structures like the parotid glands and spinal cord comparable. The RL plans also used fewer total radiation units and showed less variability, reflecting a more consistent planning strategy than human planners typically achieve.¹¹ Similar multi-agent RL approaches have been applied to lung cancer treatment planning, where the system learns to adjust multiple optimization objectives simultaneously within commercial planning software.¹²

RL has also been explored for optimizing the dose-fractionation schedule itself: how much radiation to deliver in each session and how to space sessions over time to maximize tumor-cell death while letting healthy tissue recover.¹³

Discovering New Drugs

RL has carved out a growing role in drug discovery, where the “actions” aren’t clinical decisions but molecular design choices. A system called ReLeaSE (Reinforcement Learning for Structural Evolution) pairs a generative neural network that proposes new molecular structures with a predictive network that evaluates their properties. The RL framework trains both jointly, steering the generator toward molecules with desired characteristics like specific melting points, solubility levels, or inhibitory activity against disease-relevant proteins.¹⁴

More advanced systems tackle “polypharmacology,” the challenge of designing molecules that hit multiple intended targets while avoiding off-targets that cause side effects. One framework used RL with multi-objective optimization to generate drug-like molecules aimed at two adenosine receptors while avoiding a potassium channel linked to cardiac toxicity.¹⁵ Other groups have used RL-guided generation to rediscover known active chemical scaffolds for cancer-related targets, validating that the approach can find real leads rather than just novel-looking molecules that don’t actually work.¹⁶

Hospital Operations and Scheduling

Not all healthcare RL involves bedside medicine. Emergency department patient scheduling is a natural fit for RL because the environment is dynamic, unpredictable, and involves competing priorities. A deep RL system trained to schedule ED patients outperformed standard dispatching rules at minimizing weighted waiting times while prioritizing emergent cases.¹⁷

Operating room scheduling presents an even more complex problem involving elective procedures, emergency cases, setup times, and overtime constraints all at once. A multi-agent RL framework treats each operating room as a separate agent that learns cooperatively, balancing elective throughput against urgent demand and delays.¹⁸ These logistical applications may actually reach clinical practice sooner than bedside treatment recommendations, because the stakes of a suboptimal scheduling decision are less catastrophic than a wrong drug dose.

The Safety Problem

The biggest barrier to deploying RL in clinical care is safety. Designing the reward function, the numerical signal that tells the agent what counts as “good,” turns out to be deceptively hard. Clinical outcomes, patient comfort, resource use, and adherence to guidelines all compete for weight, and healthcare interventions often have consequences that unfold over weeks or months with sparse and delayed feedback along the way.¹⁹ Get the reward wrong and the agent optimizes for the wrong thing. A model that only considers mortality as an outcome might recommend aggressive treatments that keep patients alive but cause kidney failure or other serious harm.

Researchers are building safety mechanisms directly into RL systems. One approach explicitly models multiple negative endpoints like acute kidney injury, dialysis, and septic shock, so the agent avoids high-risk treatments proactively rather than learning only from deaths.²⁰ Another uses a two-stage framework: first, the agent learns a policy with built-in clinical constraints, then a runtime safety filter checks every proposed action against established guidelines before it can be executed. In testing, this filter reduced constraint violations by over 97%.²¹

Evaluating whether an RL policy would actually work is also tricky when you can’t run a live experiment. Researchers use off-policy evaluation methods like doubly robust estimation, which combines models of patient outcomes with models of what clinicians historically did, to estimate how a new policy would perform using only old data.²² These techniques provide some confidence, but they are not substitutes for real-world testing.

Making RL Transparent to Clinicians

A black-box system that says “give this dose” and offers no explanation is unlikely to earn physician trust, and for good reason. Explainability layers are becoming a standard component of healthcare RL platforms. One system designed for orthodontic and surgical planning incorporates multiple explainable AI components that act as bridges between the model’s computations and clinical reasoning, allowing specialists to understand, validate, and override recommendations when needed.²³

Other approaches generate two types of explanations in real time: population-level summaries showing which patient features most influence the model’s decisions overall, and patient-specific rationales explaining why a particular recommendation was made for this individual right now.²⁴ The goal is a decision-support tool, not a replacement for clinical judgment. The physician sees what the model recommends and why, then decides whether to follow it.

Mobile Health and Behavioral Interventions

RL also shows up in less dramatic but potentially very impactful settings: smartphone apps and wearable-based health interventions. These “just-in-time adaptive interventions” use RL to decide when and how to nudge you toward healthy behaviors, whether that means sending an exercise reminder during a sedentary stretch or offering a stress-management tip when your heart rate variability suggests anxiety. The timing and content adapt based on your responses over time, learning what works for you specifically. Researchers have developed specialized trial designs, such as micro-randomized trials, to evaluate these interventions rigorously by randomly assigning different options at many decision points throughout the day.²⁵

Surgical Robotics

At the physical end of the spectrum, RL is being used to train robotic systems that perform or assist with surgical tasks. Research has demonstrated that RL can teach robots complex procedures like suturing and tissue manipulation, potentially improving precision beyond what human hands achieve consistently.²⁶ One specialized application uses RL to control magnetic surgical needles, where the physics of magnetic manipulation make conventional control methods difficult to program by hand. The RL agent learns to steer the needle through trial and error in simulation, bypassing the need for an exact physical model.²⁷

Synthetic Data and Patient Privacy

Training RL models requires large datasets, and healthcare data is notoriously hard to share due to privacy regulations. An emerging solution uses RL itself to generate synthetic patient records that preserve the statistical patterns of real data without exposing any individual’s information. A framework called RLSyn treats the data generator as an RL agent, rewarding it for producing records that look realistic to a discriminator model. It performs comparably to more complex generative models on large datasets and actually outperforms them on the smaller datasets common in biomedical research.²⁸ Another hybrid approach combining multiple augmentation methods through an RL-based weighting mechanism achieved strong privacy protection scores while maintaining high data fidelity.²⁹

The Other “RL” in Healthcare

If you search for “RL in healthcare” in a hospital context, you may run into a completely different meaning. Many healthcare organizations use reporting and learning systems (abbreviated RLS or RL systems) for tracking patient safety incidents. These are software platforms where clinicians document near-misses, adverse events, and system failures so the organization can learn from them. One Canadian hospital, for example, tracked physician-submitted incident reports through a platform called RLDatix as part of a quality improvement initiative.³⁰ This use of “RL” has nothing to do with artificial intelligence. It is a workflow tool for institutional safety culture, and the abbreviation overlap can cause genuine confusion when reading healthcare literature.